作者: Per Pfeiffer , Claus-Henning Köhne , Camilla Qvortrup
DOI: 10.1080/14737140.2019.1543593
关键词: Triplet chemotherapy 、 Personalized therapy 、 Treatment strategy 、 Chemotherapy 、 Medicine 、 Colorectal cancer 、 Intensive care medicine 、 Targeted therapy
摘要: ABSTRACTIntroduction: Since late 1990’s therapy of metastatic colorectal cancer (mCRC) patients has changed considerable, and the combination doublet or triplet chemotherapy a targeted agent are now routinely used. With introduction more intensified regimens, it become even important to identify that will benefit from can tolerate therapy. Furthermore, increasing understanding biology mCRC led discovery new potential targets. Therefore, with undergone considerable change ‘one strategy fits all’ towards personalized therapy.Areas covered: We present an overview recent literature on approved systemic treatment however focus how based clinical molecular parameters presently used in situation.Expert commentary: The face approach ...